I now have comprehensive information from multiple textbook sources. Here is the complete answer:
Wilson Disease
Age of Prevalence
Wilson disease (WD) is a disease of young people. Symptoms typically appear between 6 and 40 years of age, though onset as late as the fifth or sixth decade has been reported in rare cases. The most common presentation is in the second decade of life (adolescence/young adulthood). An acute presentation - often as acute liver failure - typically occurs in the second decade and accounts for up to 25% of cases.
- Robbins & Kumar Basic Pathology, p. 615
- Bradley & Daroff's Neurology in Clinical Practice, p. 3800
What Raises Suspicion of Wilson Disease?
1. Clinical Presentation Pattern
About one-third of patients present in each of three ways:
- Hepatic disease (acute hepatitis, chronic hepatitis, or cirrhosis)
- Neurological features (extrapyramidal: tremor, chorea, dystonia, dysarthria, dysphagia, ataxia, gait disturbance)
- Psychiatric symptoms (personality/mood changes, depression ~30%, bipolar features ~20%, psychosis)
Any young patient (especially <40 years) with unexplained liver disease plus neuropsychiatric features should raise immediate suspicion.
2. The Kayser-Fleischer (KF) Ring
The hallmark clinical sign. A yellow-brown/green-brown copper deposit in the Descemet membrane at the limbus of the cornea.
- Present in 98% of patients with neurological disease
- Present in ~80% of all cases of WD
- Best seen on slit-lamp examination
- Nearly all patients with neurological involvement have KF rings
3. Specific Clue in Acute Liver Failure (ALF)
When a young patient presents with ALF, Wilson disease is suspected when:
- Serum alkaline phosphatase : total bilirubin ratio < 4 (low ALP is unusual for most liver diseases)
- AST : ALT ratio > 2.2
- Unconjugated hyperbilirubinemia from hemolysis (Coombs-negative hemolytic anemia)
- Ascites as an early feature (suggesting underlying cirrhosis)
4. Laboratory Red Flags
| Test | Finding in Wilson Disease |
|---|
| Serum ceruloplasmin | Low (hallmark, though not the most sensitive) |
| 24-hour urinary copper | Elevated (most specific test) |
| Hepatic copper content | >250 µg/g dry weight (most sensitive; diagnostic at this level) |
| Serum copper | Unreliable - may be low, normal, or high depending on disease stage |
| Serum ALP | Paradoxically low in acute Wilson ALF |
5. Organ Systems Affected - Red Flags by System
| System | Suspicious Finding |
|---|
| Liver | Unexplained hepatitis, steatosis, cirrhosis in a young person |
| Neuro | Tremor, dystonia, dysarthria, ataxia in young age |
| Eye | Kayser-Fleischer rings on slit-lamp |
| Psychiatric | Personality change, depression, psychosis in a young person with hepatic disease |
| Blood | Coombs-negative hemolytic anemia (copper causes RBC hemolysis) |
| Kidney/Bone | Renal tubular acidosis, osteoporosis, fractures in young patients |
Pathophysiology Summary
Fig. 14.22 from Robbins & Kumar: ATP7B mutation impairs both biliary copper excretion and ceruloplasmin formation, causing copper accumulation in hepatocytes and downstream toxicity to brain, corneas, kidneys, and bones.
WD is autosomal recessive, caused by loss-of-function mutations in ATP7B (chromosome 13), a copper-transporting ATPase. The result is:
- Copper cannot be excreted into bile (primary copper excretion route)
- Copper cannot be incorporated into apoceruloplasmin → low serum ceruloplasmin
- Hepatic copper accumulates → hepatocyte injury → copper spills into blood
- Free copper deposits in brain (basal ganglia), corneas, kidneys, joints, parathyroid glands
Sources: Robbins & Kumar Basic Pathology, pp. 614-616 | Bradley & Daroff's Neurology in Clinical Practice, p. 3800 | Sleisenger & Fordtran's GI and Liver Disease, p. 1838